Pharm Sci Seminar–Geoff Zhang, PhD
Amorphous solid dispersions (ASDs) have been widely used for delivering poorly water soluble pharmaceuticals in recent years
Stay up-to-date with the latest events, including faculty presentations, career events for students and alumni, and so much more.
Amorphous solid dispersions (ASDs) have been widely used for delivering poorly water soluble pharmaceuticals in recent years
Neuromodulators are signaling molecules that can rapidly broadcast messages to large populations of neurons and exert profound effects on behavior.
Despite the enormous health, social, and economic burdens that psychiatric illnesses have placed on the United States, the rate of entry into clinical trials for central nervous system (CNS) therapeutics is decreasing, as are the rates of success for those CNS compounds that do make it into human trials.
Cyclin D-CDK4/6 are components of the core cell cycle machinery that drives cell proliferation.
Chronic myeloid leukemia, CML, is driven by ABL1 and the introduction of highly effective kinase inhibitors, such as imatinib, has resulted in a 5-year survival rate for CML to approach 90%.
The metabolism of proliferating cancer cells not only generates energy, but also synthesizes the biomolecules required for growth.
Nature performs challenging synthetic transformations using powerful enzymes. These enzymes are frequently found in the biosynthetic pathways of natural products
It is now possible to estimate the natural product biosynthetic potential of organisms before attempting to isolate compounds by analysis of their biosynthetic gene clusters.
In order to identify and assess sequence markers that support structure and specificity, we have undertaken the study of two enzyme superfamilies, comprising phosphotransferases and phosphoglycosyltransferases, the haloalkanoate dehalogenase superfamily (HADSF) and the phosphoglycosyl transferase superfamily (PGT)
The recent clinical success of IL-17A neutralizing biologics in psoriasis has underlined its importance as a target for drug discovery